CAS: 951151-97-6
(E)-1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-yloxy)-2-chlorophenyl)-3-ethylurea
CAS:951151-97-6
Formula:
C15H17ClN6O3
Purity:
98%
Molecular weight:
364.7869
Ref: IN-DA01DNTJ
| 10mg | 118.00 € | ||
| 25mg | 166.00 € | ||
| 50mg | 189.00 € | ||
| 100mg | 299.00 € |
Estimated delivery in United States, on Thursday 27 Mar 2025
Ref: 7W-GW9904
| 1mg | 506.00 € | ||
| 5mg | 952.00 € | ||
| 10mg | 1,324.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
JNJ-38158471
CAS:951151-97-6
JNJ-38158471 (CS-2660), a highly selective, orally available, well tolerated VEGFR2 inhibitor, inhibits closely related tyrosine …
Formula:
C15H17ClN6O3
Purity:
97.08%
Color and Shape:
Solid
Molecular weight:
364.79
- Inhibitors
- Tyrosine Kinase/Adaptors
- VEGFR
- c-Kit
- See more categories
- Cancer Research Antibodies
Ref: TM-T22349
| 1mg | 52.00 € | ||
| 2mg | 74.00 € | ||
| 5mg | 105.00 € | ||
| 10mg | 156.00 € | ||
| 25mg | 259.00 € | ||
| 50mg | 378.00 € | ||
| 100mg | 509.00 € | ||
| 200mg | 698.00 € | ||
| 1mL*10mM (DMSO) | 113.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
JNJ-38158471
CAS:951151-97-6
JNJ-38158471 is a tyrosine kinase inhibitor that has been shown to have anticancer activity. It …
Formula:
C15H17ClN6O3
Purity:
Min. 95%
Molecular weight:
364.79 g/mol
Ref: 3D-BNB15197
| 1mg | 331.00 € | ||
| 5mg | 673.00 € | ||
| 10mg | 1,026.00 € | ||
| 25mg | 1,810.00 € | ||
| 50mg | 2,895.00 € |
Estimated delivery in United States, on Thursday 8 May 2025
